AML blasts express high levels of ligands, such as CD112 and CD155, that cause a decrease in their activating receptor DNAM-1 on NKs, ultimately leading to an altered degranulation of NKs and impaired cytotoxic activity [39, 40]. This evidence concerns the gene NECTIN2 and acute myeloid leukemia.